CJMB Callan JMB Inc.
Callan JMB Inc., through its subsidiary, Coldchain Technology Services, LLC provides thermal management logistics solutions to the life sciences industry in United States. It offers logistics solutions and services utilized for frozen shipping in the life sciences industry, including personalized medicine, cell therapies, stem cells, cell lines, vaccines, diagnostic materials, semen, eggs, embryos, cord blood, organs, biopharmaceuticals, infectious substances, and other commodities. The company also provides emergency preparedness services, which includes managing their building sites, medical stockpiles of equipment, and supplies and responding to state or local emergencies; specialty temperature-regulating packaging; technical services; and advanced monitoring sentry technology. In addition, the company engages in oil and gas development business. Callan JMB Inc. has strategic partnership with Alabama State University to advance the United States pharmaceutical manufacturing and supply chain resilience. The company was founded in 2006 and is headquartered in Spring Branch, Texas.…
Industry Peers
Integrated Freight & LogisticsKey Statistics
About Callan JMB (NASDAQ: CJMB)
›
Callan JMB (NASDAQ: CJMB) is listed on Nasdaq, where its shares trade in USD. It belongs to the Integrated Freight & Logistics industry, part of the Industrials sector, and reports about 18 employees.
The shares were at 0.3240 USD on 19 November 2026, down 89.6% over 52 weeks. Its 52-week range is 0.2600 USD to 5.610 USD: the price is 94.2% below the high and 24.6% above the low.
Its market capitalisation is 3.45M USD.
Callan JMB reports return on equity of -342.2%, an operating margin of -152.6% and revenue down 20.7% year over year.
Its debt exceeds its cash by 1.28M USD, a debt-to-equity ratio of 0.86. Its Piotroski F-score is 1 out of 9, a weak reading of its financial health.